Drug-induced, dependent on the Wnt/βcatenin signaling pathway, miR-219-5p targeted inhibition of glypican-3 (GPC3) inhibited HCC cell proliferation, migration, and invasion (Gong et al., 2019). The gene discussed is GPC3; the disease is hepatocellular carcinoma.